Phase III trial of controlled-release budesonide in patients with IgA nephropathy.
Phase of Trial: Phase III
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Budesonide (Primary)
- Indications IgA nephropathy
- Focus Registrational; Therapeutic Use
- Sponsors Pharmalink AB
- 09 Jan 2017 According to a Pharmalink media release, this trial is expected to begin in 2017.
- 26 Nov 2013 New trial record